In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit (Q37381314)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit |
scientific article |
Statements
1 reference
In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit (English)
1 reference
Aftab A Ansari
1 reference
Francois Villinger
1 reference
Praveen K Amancha
1 reference
Jung Joo Hong
1 reference
Kenneth Rogers
1 reference
13 November 2013
1 reference
1 reference
6060-6070
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference